2018 Q1 Form 10-Q Financial Statement
#000114420418025403 Filed on May 04, 2018
Income Statement
Concept | 2018 Q1 | 2017 Q1 |
---|---|---|
Revenue | $96.46M | $84.12M |
YoY Change | 14.66% | 14.17% |
Cost Of Revenue | $5.800M | $3.700M |
YoY Change | 56.76% | -5.13% |
Gross Profit | $90.70M | $80.50M |
YoY Change | 12.67% | 15.33% |
Gross Profit Margin | 94.03% | 95.69% |
Selling, General & Admin | $61.60M | $58.60M |
YoY Change | 5.12% | 20.82% |
% of Gross Profit | 67.92% | 72.8% |
Research & Development | ||
YoY Change | ||
% of Gross Profit | ||
Depreciation & Amortization | $1.600M | $1.600M |
YoY Change | 0.0% | 6.67% |
% of Gross Profit | 1.76% | 1.99% |
Operating Expenses | $74.86M | $69.49M |
YoY Change | 7.73% | 25.2% |
Operating Profit | $21.60M | $14.63M |
YoY Change | 47.59% | 2.49% |
Interest Expense | $500.0K | $200.0K |
YoY Change | 150.0% | 100.0% |
% of Operating Profit | 2.32% | 1.37% |
Other Income/Expense, Net | $852.0K | $2.776M |
YoY Change | -69.31% | 73.5% |
Pretax Income | $22.45M | $17.41M |
YoY Change | 28.95% | 8.83% |
Income Tax | $2.110M | $834.0K |
% Of Pretax Income | 9.4% | 4.79% |
Net Earnings | $20.34M | $16.58M |
YoY Change | 22.71% | 68.28% |
Net Earnings / Revenue | 21.09% | 19.7% |
Basic Earnings Per Share | $0.39 | $0.32 |
Diluted Earnings Per Share | $0.38 | $0.31 |
COMMON SHARES | ||
Basic Shares Outstanding | 52.74M | 52.60M |
Diluted Shares Outstanding | 54.01M | 53.96M |
Balance Sheet
Concept | 2018 Q1 | 2017 Q1 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $178.6M | $154.9M |
YoY Change | 15.3% | -9.73% |
Cash & Equivalents | $103.2M | $87.09M |
Short-Term Investments | $75.50M | $67.80M |
Other Short-Term Assets | $9.600M | $12.40M |
YoY Change | -22.58% | -1.59% |
Inventory | ||
Prepaid Expenses | ||
Receivables | $117.2M | $96.35M |
Other Receivables | $0.00 | $0.00 |
Total Short-Term Assets | $305.5M | $263.6M |
YoY Change | 15.89% | -3.36% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $40.40M | $36.57M |
YoY Change | 10.47% | 28.39% |
Goodwill | $8.607M | |
YoY Change | 0.0% | |
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | $86.00M | $952.0K |
YoY Change | 8933.61% | -42.34% |
Total Long-Term Assets | $135.0M | $134.6M |
YoY Change | 0.28% | 17.31% |
TOTAL ASSETS | ||
Total Short-Term Assets | $305.5M | $263.6M |
Total Long-Term Assets | $135.0M | $134.6M |
Total Assets | $440.5M | $398.2M |
YoY Change | 10.61% | 2.76% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $16.50M | $10.20M |
YoY Change | 61.76% | 181.61% |
Accrued Expenses | $45.20M | $41.10M |
YoY Change | 9.98% | 490.69% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $69.60M | $57.42M |
YoY Change | 21.22% | -28.65% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Other Long-Term Liabilities | $64.20M | $2.117M |
YoY Change | 2932.59% | 10.66% |
Total Long-Term Liabilities | $64.20M | $2.117M |
YoY Change | 2932.59% | 10.66% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $69.60M | $57.42M |
Total Long-Term Liabilities | $64.20M | $2.117M |
Total Liabilities | $133.8M | $113.5M |
YoY Change | 17.93% | -9.02% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | $296.0M | |
YoY Change | 9.94% | |
Common Stock | $205.3M | |
YoY Change | 14.15% | |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | $213.7M | |
YoY Change | 15.81% | |
Treasury Stock Shares | 6.849M shares | 6.982M shares |
Shareholders Equity | $306.6M | $284.7M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $440.5M | $398.2M |
YoY Change | 10.62% | 2.75% |
Cashflow Statement
Concept | 2018 Q1 | 2017 Q1 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | $20.34M | $16.58M |
YoY Change | 22.71% | 68.28% |
Depreciation, Depletion And Amortization | $1.600M | $1.600M |
YoY Change | 0.0% | 6.67% |
Cash From Operating Activities | $3.692M | -$1.784M |
YoY Change | -306.95% | -106.81% |
INVESTING ACTIVITIES | ||
Capital Expenditures | $6.810M | $1.307M |
YoY Change | 421.04% | -230.7% |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | -$3.900M | -$9.000M |
YoY Change | -56.67% | -53.37% |
Cash From Investing Activities | -$10.74M | -$10.31M |
YoY Change | 4.24% | -48.98% |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | $6.959M | $5.374M |
YoY Change | 29.49% | |
Common Stock Issuance & Retirement, Net | $0.00 | $1.304M |
YoY Change | -100.0% | |
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | -15.29M | -$15.91M |
YoY Change | -3.91% | 253.51% |
NET CHANGE | ||
Cash From Operating Activities | 3.692M | -$1.784M |
Cash From Investing Activities | -10.74M | -$10.31M |
Cash From Financing Activities | -15.29M | -$15.91M |
Net Change In Cash | -21.64M | -$28.00M |
YoY Change | -22.7% | -1966.6% |
FREE CASH FLOW | ||
Cash From Operating Activities | $3.692M | -$1.784M |
Capital Expenditures | $6.810M | $1.307M |
Free Cash Flow | -$3.118M | -$3.091M |
YoY Change | 0.87% | -111.36% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2018Q1 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
322000 | USD |
CY2017Q1 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
2542000 | USD |
CY2018Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
20340000 | USD |
CY2017Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
16576000 | USD |
CY2018Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.77 | |
CY2017Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.63 | |
CY2018Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.75 | |
CY2017Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.61 | |
CY2018Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
26372000 | shares |
CY2017Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
26302000 | shares |
CY2018Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
27006000 | shares |
CY2017Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
26981000 | shares |
CY2018Q1 | us-gaap |
Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
|
0.26 | |
CY2017Q1 | us-gaap |
Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
|
0.21 | |
CY2018Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
22450000 | USD |
CY2017Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
17410000 | USD |
CY2018Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
2110000 | USD |
CY2017Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
834000 | USD |
CY2018Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
21039000 | USD |
CY2017Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
16748000 | USD |
CY2018Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
1555000 | USD |
CY2017Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
1566000 | USD |
CY2018Q1 | us-gaap |
Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
|
-74000 | USD |
CY2017Q1 | us-gaap |
Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
|
-129000 | USD |
CY2018Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
561000 | USD |
CY2017Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
458000 | USD |
CY2018Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
6289000 | USD |
CY2017Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
5655000 | USD |
CY2018Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-815000 | USD |
CY2017Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
426000 | USD |
CY2018Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
7700000 | USD |
CY2017Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
9395000 | USD |
CY2018Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
5520000 | USD |
CY2017Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
2974000 | USD |
CY2017Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
36000 | USD |
CY2018Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-40000 | USD |
CY2018Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
1829000 | USD |
CY2017Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
3000 | USD |
CY2018Q1 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-12383000 | USD |
CY2017Q1 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-12491000 | USD |
CY2018Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-390000 | USD |
CY2017Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-1479000 | USD |
CY2018Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
3692000 | USD |
CY2017Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1784000 | USD |
CY2018Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
6810000 | USD |
CY2017Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1307000 | USD |
CY2018Q1 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
|
8000000 | USD |
CY2017Q1 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
|
0 | USD |
CY2018Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-10744000 | USD |
CY2017Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-10307000 | USD |
CY2018Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
8637000 | USD |
CY2017Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
9517000 | USD |
CY2018Q1 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
0 | USD |
CY2017Q1 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
1304000 | USD |
CY2018Q1 | us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
310000 | USD |
CY2017Q1 | us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
287000 | USD |
CY2018Q1 | us-gaap |
Payments Of Dividends
PaymentsOfDividends
|
6959000 | USD |
CY2017Q1 | us-gaap |
Payments Of Dividends
PaymentsOfDividends
|
5374000 | USD |
CY2018Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-15286000 | USD |
CY2017Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-15908000 | USD |
CY2018Q1 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
696000 | USD |
CY2017Q1 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
118000 | USD |
CY2018Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-21642000 | USD |
CY2017Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-27881000 | USD |
CY2016Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
114967000 | USD |
CY2017Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
87086000 | USD |
CY2018Q1 | us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
11934000 | USD |
CY2017Q1 | us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
9000000 | USD |
CY2018Q1 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
139614000 | USD |
CY2018Q1 | expo |
Deferred Compensation Plan Liabilities Fair Value Disclosure
DeferredCompensationPlanLiabilitiesFairValueDisclosure
|
65611000 | USD |
CY2018Q1 | us-gaap |
Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
|
65611000 | USD |
CY2017Q4 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
134696000 | USD |
CY2017Q4 | us-gaap |
Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
|
59050000 | USD |
CY2018Q1 | expo |
Available For Sale Securities Short Term Investments Amortized Cost Due In Year One
AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCostDueInYearOne
|
47927000 | USD |
CY2018Q1 | expo |
Available For Sale Securities Short Term Investments Amortized Cost Due In Year Two
AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCostDueInYearTwo
|
28004000 | USD |
CY2018Q1 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
75931000 | USD |
CY2018Q1 | expo |
Available For Sale Securities Short Term Investments Estimated Fair Value Due In Year One
AvailableForSaleSecuritiesShortTermInvestmentsEstimatedFairValueDueInYearOne
|
47725000 | USD |
CY2018Q1 | expo |
Available For Sale Securities Short Term Investments Estimated Fair Value Due In Year Two
AvailableForSaleSecuritiesShortTermInvestmentsEstimatedFairValueDueInYearTwo
|
27760000 | USD |
CY2018Q1 | us-gaap |
Trading Securities
TradingSecurities
|
58058000 | USD |
CY2017Q4 | us-gaap |
Trading Securities
TradingSecurities
|
53350000 | USD |
CY2018Q1 | expo |
Deferred Compensation Plan Vested Amounts Due
DeferredCompensationPlanVestedAmountsDue
|
65611000 | USD |
CY2017Q4 | expo |
Deferred Compensation Plan Vested Amounts Due
DeferredCompensationPlanVestedAmountsDue
|
59050000 | USD |
CY2017Q1 | expo |
Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
|
1898000 | USD |
CY2018Q1 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
678000 | USD |
CY2017Q1 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
446000 | USD |
CY2018Q1 | expo |
Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
|
7643000 | USD |
CY2017Q1 | expo |
Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
|
6910000 | USD |
CY2018Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
299000 | USD |
CY2017Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
405000 | USD |
CY2017Q4 | us-gaap |
Assets
Assets
|
439589000 | USD |
CY2018Q1 | us-gaap |
Assets
Assets
|
440459000 | USD |
CY2018Q1 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-1330000 | USD |
CY2017Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-2029000 | USD |
CY2018Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
440459000 | USD |
CY2017Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
439589000 | USD |
CY2018Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
74859000 | USD |
CY2017Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
69488000 | USD |
CY2018Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
852000 | USD |
CY2017Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
2776000 | USD |
CY2018Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
3805000 | USD |
CY2017Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
3526000 | USD |
CY2018Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2017Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2018Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
80000000 | shares |
CY2017Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
80000000 | shares |
CY2018Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
32853000 | shares |
CY2017Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
32853000 | shares |
CY2018Q1 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
6849000 | shares |
CY2017Q4 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
7084000 | shares |
CY2018Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt">Use of Estimates. <font style="FONT-WEIGHT: normal">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Items subject to such estimates and assumptions include accounting for revenue recognition and estimating the allowance for contract losses and doubtful accounts. Actual results could differ from those estimates.</font></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
CY2015Q4 | us-gaap |
Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
|
35000000 | USD |
CY2016Q4 | us-gaap |
Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
|
35000000 | USD |
CY2017Q1 | us-gaap |
Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
|
22666 | shares |
CY2017Q1 | us-gaap |
Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
|
1304000 | USD |
CY2018Q1 | us-gaap |
Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
|
45376000 | USD |
CY2018Q1 | expo |
Entity Wide Sales Revenue Major Customer
EntityWideSalesRevenueMajorCustomer
|
0.1 | pure |
CY2017Q1 | expo |
Entity Wide Sales Revenue Major Customer
EntityWideSalesRevenueMajorCustomer
|
0.1 | pure |
CY2017Q4 | us-gaap |
Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
|
5416000 | USD |
CY2017 | us-gaap |
Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
|
21638000 | USD |
CY2018Q1 | us-gaap |
Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
|
0.26 | |
CY2018Q1 | us-gaap |
Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
|
6700000 | USD |
CY2018Q1 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
179083000 | USD |
CY2018Q1 | expo |
Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
|
0 | USD |
CY2018Q1 | expo |
Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
|
446000 | USD |
CY2018Q1 | expo |
Cash Cash Equivalents And Short Term Investments Fair Value Disclosure
CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure
|
178637000 | USD |
CY2017Q4 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
196791000 | USD |
CY2017Q4 | expo |
Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
|
0 | USD |
CY2017Q4 | expo |
Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
|
393000 | USD |
CY2017Q4 | expo |
Cash Cash Equivalents And Short Term Investments Fair Value Disclosure
CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure
|
196398000 | USD |
CY2017Q1 | us-gaap |
Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
|
0.21 | |
CY2017Q2 | us-gaap |
Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
|
0.21 | |
CY2017Q3 | us-gaap |
Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
|
0.21 | |
CY2017Q4 | us-gaap |
Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
|
0.21 | |
CY2017 | us-gaap |
Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
|
0.84 | |
CY2017Q1 | us-gaap |
Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
|
5374000 | USD |
CY2017Q2 | us-gaap |
Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
|
5424000 | USD |
CY2017Q3 | us-gaap |
Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
|
5424000 | USD |
CY2018Q1 | expo |
Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
|
-305000 | USD |
CY2018Q1 | us-gaap |
Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
|
6071000 | USD |
CY2017Q4 | us-gaap |
Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
|
9742000 | USD |
CY2017Q4 | expo |
Deferred Compensation Plan Liabilities Fair Value Disclosure
DeferredCompensationPlanLiabilitiesFairValueDisclosure
|
59050000 | USD |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
592592 | shares |
CY2018Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
198846 | shares |
CY2018Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
|
267760 | shares |
CY2018Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
|
0 | shares |
CY2018Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
523678 | shares |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
45.91 | |
CY2018Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
80.14 | |
CY2018Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
|
54.28 | |
CY2018Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
|
0 | |
CY2018Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
54.63 | |
CY2018Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
|
P2Y3M18D | |
CY2018Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested
|
41187000 | USD |
CY2018Q1 | us-gaap |
Share Price
SharePrice
|
78.65 | |
CY2018Q1 | us-gaap |
Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
|
2604000 | USD |